0001178913-18-001607.txt : 20180510 0001178913-18-001607.hdr.sgml : 20180510 20180510174042 ACCESSION NUMBER: 0001178913-18-001607 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180508 FILED AS OF DATE: 20180510 DATE AS OF CHANGE: 20180510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAZANCHYAN ANNA CENTRAL INDEX KEY: 0001369219 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36621 FILM NUMBER: 18824263 MAIL ADDRESS: STREET 1: 933 MAMARONECK AVENUE STREET 2: SUITE 103 CITY: MAMARONECK STATE: NY ZIP: 10543 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foamix Pharmaceuticals Ltd. CENTRAL INDEX KEY: 0001606645 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 BUSINESS PHONE: 97289316233 MAIL ADDRESS: STREET 1: 2 HOLZMAN ST. STREET 2: WEIZMANN SCIENCE PARK CITY: REHOVOT STATE: L3 ZIP: 76704 FORMER COMPANY: FORMER CONFORMED NAME: Foamix Ltd. DATE OF NAME CHANGE: 20140428 4 1 zk1821665.xml OWNERSHIP DOCUMENT X0306 4 2018-05-08 0 0001606645 Foamix Pharmaceuticals Ltd. FOMX 0001369219 KAZANCHYAN ANNA C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLTZMAN STREET REHOVOT L3 7670402 ISRAEL 1 0 0 0 Ordinary Shares 2018-05-08 4 A 0 14829 0.00 A 27760 D This security represents restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer. The ordinary shares underlying this restricted share unit award vest over a period of three years from May 8, 2018 (33.3% on each anniversary of such date) and ending May 8, 2021. The issuer's method of reporting restricted share units has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, this amount includes (i) 12,931 ordinary shares subject to unvested restricted share units that were previously reported in Table II of the reporting person's Form 3 as a derivative security and ii) the 14,829 ordinary shares sub-ject to unvested restricted share units granted on May 8, 2018 and first reported on this Form 4. /s/ _Ilan Hadar as attorney-in-fact for Anna Kazanchyan 2018-05-10